Literature DB >> 7896662

Can clozapine trigger OCD?

Y Levkovitch, Y Kronnenberg, B Gaoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7896662     DOI： 10.1097/00004583-199503000-00005

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  7 in total

1.  Fewer classes of drugs for more and more psychiatric disorders.

Authors:  L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2006-03       Impact factor: 6.186

Review 2.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

3.  Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS.

Authors:  A Khullar; P Chue; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

Review 4.  Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Authors:  Michael Poyurovsky; Abraham Weizman; Ronit Weizman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.

Authors:  P Tibbo; L Warneke
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

6.  The experience of patients with schizophrenia treated with repetitive transcranial magnetic stimulation for auditory hallucinations.

Authors:  Priya Subramanian; Amer Burhan; Luljeta Pallaveshi; Abraham Rudnick
Journal:  Case Rep Psychiatry       Date:  2013-06-02

Review 7.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.